Weight Management Program — Addressing the Hormonal Drivers, Not Just the Number on the Scale
Weight management in women is not simply a matter of calories and exercise — and treating it as such ignores the hormonal, metabolic, and gynecologic factors that drive weight gain and make it resistant to conventional approaches. Insulin resistance, thyroid dysfunction, estrogen decline, PCOS-related androgen excess, and cortisol dysregulation all contribute to weight accumulation that diet and exercise alone cannot fully address.
At Lapeer Women’s Health, the weight management program starts with identifying what is actually driving your weight — through targeted hormonal and metabolic lab testing — and builds a management plan that addresses those specific contributors. This is not a diet program or a wellness package. It is gynecologic medicine applied to a clinical problem that has clear hormonal underpinnings in a significant proportion of women.
Dr. Andrei integrates medical weight management — including GLP-1 receptor agonist therapy where appropriate — with hormonal optimization, PCOS management, and menopause care. For many patients, addressing the hormonal contributors alongside or before medication produces significantly better and more sustainable results than medication alone. See also: Gynecologic Hormone & Lab Testing for the specific panels Dr. Andrei orders in the weight evaluation.
What Dr. Andrei Evaluates Before Treating
These are the hormonal and metabolic contributors to weight gain that Dr. Andrei identifies and addresses as part of the weight management program.
Insulin resistance
The most common metabolic driver of weight gain in reproductive-age women — and the central mechanism of PCOS-related weight accumulation. Elevated fasting insulin with normal or mildly elevated glucose indicates significant insulin resistance even before the prediabetes threshold is reached. Identifying it directs specific treatment with insulin-sensitizing strategies and informs dietary recommendations.
Thyroid dysfunction
Hypothyroidism — including subclinical hypothyroidism with mildly elevated TSH and normal Free T4 — reduces metabolic rate, impairs fat oxidation, and causes weight gain that does not respond to dietary restriction. Treating hypothyroidism normalizes metabolic rate and produces modest but meaningful weight improvement as one component of a broader management plan.
Estrogen decline and menopause
Estrogen loss at menopause drives visceral fat redistribution, reduced muscle mass, increased insulin resistance, and reduced metabolic rate — producing the characteristic central weight gain of the menopausal transition. Hormone therapy initiated at or near menopause attenuates this shift. Managing menopausal weight requires addressing the hormonal context, not just caloric intake.
PCOS and androgen excess
Insulin resistance is the central metabolic driver of PCOS — elevated androgens worsen insulin sensitivity, and insulin resistance drives further androgen production. PCOS-related weight is particularly resistant to diet and exercise alone. Metformin, inositol, and GLP-1 receptor agonists all target the insulin resistance mechanism that underlies both the weight and the hormonal dysregulation.
Medication-related weight gain
Antidepressants, antipsychotics, insulin, sulfonylureas, corticosteroids, hormonal contraceptives, and some other medications cause clinically significant weight gain. Dr. Andrei reviews your complete medication list for weight-promoting agents and discusses alternatives or mitigation strategies when the clinical picture supports a change.
GLP-1 receptor agonist therapy
Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) represent a significant advance in medical weight management. Dr. Andrei discusses candidacy, prescribes when appropriate, and manages these medications with the hormonal and metabolic context in view — not as a standalone prescription without comprehensive evaluation.
Why Weight Management Belongs in Gynecologic Care
Gynecology sits at the intersection of the hormonal systems that most powerfully drive weight in women. The same visit that manages PCOS, menopause, or thyroid disease is the right place to address weight — because the causes are connected.
- PCOS management and weight management are the same clinical problem — insulin resistance drives both
- Menopause care that includes hormone therapy addresses estrogen-related visceral fat redistribution directly
- Thyroid evaluation is a standard component of the gynecologic hormonal workup — not a separate referral
- Lab panels for weight evaluation overlap significantly with gynecologic hormone panels — ordered together, not in separate silos
- GLP-1 therapy is most effective when hormonal contributors are identified and managed alongside it — not prescribed in isolation
- Weight affects gynecologic health directly — fibroid growth, PCOS severity, menstrual regularity, and fertility are all weight-sensitive
“When a woman gains 20 pounds during perimenopause despite eating the same way she has for years, that is not a failure of willpower — that is estrogen withdrawal changing her metabolism. When a woman with PCOS cannot lose weight on a low-calorie diet, that is insulin resistance, not lack of effort. Identifying the actual driver changes what we do about it.”
- Initial evaluation includes targeted hormonal and metabolic lab panel
- PCOS workup included when irregular cycles or androgen excess is present
- GLP-1 candidacy assessed at the same visit as hormonal evaluation
- Nutrition and lifestyle guidance provided in the context of your specific hormonal picture
- Follow-up visits to monitor lab response, medication tolerance, and progress
- Endocrinology referral coordinated when diabetes management or complex metabolic disease requires subspecialty involvement
Questions About the Weight Management Program
Address the Hormonal Driver.
Not Just the Number.
Hormonal evaluation, targeted lab testing, GLP-1 therapy when indicated, and integration with PCOS and menopause care — weight management as part of comprehensive gynecologic medicine.
The information on this page is intended for educational purposes only and does not constitute medical advice. Individual symptoms, diagnoses, and treatment options vary significantly. Reading this content does not establish a physician-patient relationship with Dr. Ramona D. Andrei or Lapeer Women’s Health. If you are experiencing a medical emergency, call 911 or go to the nearest emergency room immediately. Please consult a qualified healthcare provider for advice specific to your situation. Content reviewed by Dr. Ramona D. Andrei, MD PhD FACOG.
Gynecologic care for women of every age
Lapeer Women’s Health — Rochester Hills
2710 S Rochester Rd, Suite 2
Rochester Hills, MI 48307
Serving patients in Lapeer, Rochester Hills, and surrounding communities throughout Southeast Michigan.